Drug Shortage Report for EPINEPHRINE INJECTION USP
| Report ID | 253333 |
| Drug Identification Number | 02435810 |
| Brand name | EPINEPHRINE INJECTION USP |
| Common or Proper name | EPINEPHRINE INJECTION USP |
| Company Name | HIKMA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | EPINEPHRINE |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRATRACHEAL INTRAMUSCULAR INTRACARDIAC SUBCUTANEOUS INTRAVENOUS INTRATRACHEAL INTRAMUSCULAR INTRACARDIAC |
| Packaging size | 1mL |
| ATC code | C01CA |
| ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | 2025-04-01 |
| Actual start date | |
| Estimated end date | 2025-05-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-04-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 55 STANDISH COURT, SUITE 1050 MISSISSAUGA, ONTARIO CANADA L5R 0G3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-04-02 | English | Compare |
| v2 | 2025-03-24 | French | Compare |
| v1 | 2025-03-24 | English | Compare |
Showing 1 to 3 of 3